Photo of Brendan Prideaux

Brendan Prideaux, PhD

  • 1072 Citations
  • 15 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Brendan Prideaux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Mass spectrometry Chemical Compounds
Pharmaceutical Preparations Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Imaging techniques Chemical Compounds
Mass Spectrometry Medicine & Life Sciences
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry Medicine & Life Sciences
Tissue Chemical Compounds
Pyrazinamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 1072 Citations
  • 15 h-Index
  • 27 Article
  • 4 Review article
  • 3 Comment/debate
  • 1 Chapter
1 Citation (Scopus)

Beyond tissue concentrations: Antifungal penetration at the site of infection

Zhao, Y., Prideaux, B., Baistrocchi, S., Sheppard, D. C. & Perlin, D. S., Apr 1 2019, In : Medical Mycology. 57, p. S161-S167

Research output: Contribution to journalReview article

Infection
Pharmaceutical Preparations
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Morbidity
Mortality

Erratum: Determination of [11C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5768-5774) 10.1128/AAC.01146-15)

DeMarco, V. P., Ordonez, A. A., Klunk, M., Prideaux, B., Wang, H., Zhang, Z., Tonge, P. J., Dannals, R. F., Holt, D. P., Lee, C. K. K., Weinstein, E. A., Dartois, V., Dooley, K. E. & Jain, S. K., Jan 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 9, e01368-19.

Research output: Contribution to journalComment/debate

Open Access
Rifampin
Anti-Infective Agents
Mycobacterium tuberculosis
Positron-Emission Tomography
Names
2 Citations (Scopus)

Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations

Sarathy, J., Blanc, L., Alvarez-Cabrera, N., O’Brien, P., Dias-Freedman, I., Mina, M., Zimmerman, M., Kaya, F., Liang, H. P. H., Prideaux, B., Dietzold, J., Salgame, P., Savic, R. M., Linderman, J., Kirschner, D., Pienaar, E. & Dartois, V., May 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 5, e02516-18.

Research output: Contribution to journalArticle

Fluoroquinolones
Tuberculosis
Multidrug-Resistant Tuberculosis
Levofloxacin
Population
2 Citations (Scopus)

Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease

Lee, A., Prideaux, B., Lee, M. H., Zimmerman, M., Dolgov, E., Perlin, D. S. & Zhao, Y., Jun 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 6, e00524-19.

Research output: Contribution to journalArticle

Chronic Granulomatous Disease
Aspergillosis
Tissue Distribution
Infection
Prodrugs
4 Citations (Scopus)

High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types

Blanc, L., Daudelin, I. B., Podell, B. K., Chen, P. Y., Zimmerman, M., Martinot, A. J., Savic, R. M., Prideaux, B. & Dartois, V., Nov 1 2018, In : eLife. 7, e41115.

Research output: Contribution to journalArticle

Open Access
Macrophages
Fluoroquinolones
Tuberculosis
Rabbits
Pharmaceutical Preparations